EtoricoxibEtoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood). A specific inhibitor of COX-2.
Specifications and Purity: ≥98%
MDL Number: MFCD06797512
Molecular Formula: C18H15ClN2O2S
Molecular Weight: 358.84
PubChem CID: 123619
Isomeric SMILES: CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
Beilstein Registry Number: 8073797
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/E126660-SCI_96f905ae888e1462ea6a272196797c43.pdf
- UPC:
- 41104121
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- E126660-1g
- CAS:
- 202409-33-4
- Product Size:
- 1g
akash.verma@cenmed.com
(732) 447-1115





